Blanch-Lombarte, O., Santos, J. R., Peña, R., Jiménez-Moyano, E., Clotet, B., Paredes, R., & Prado, J. G. (2020). HIV-1 Gag mutations alone are sufficient to reduce darunavir susceptibility during virological failure to boosted PI therapy. J Antimicrob Chemother.

Blanch-Lombarte, Oscar, José R. Santos, Ruth Peña, Esther Jiménez-Moyano, Bonaventura Clotet, Roger Paredes, und Julia G. Prado. "HIV-1 Gag Mutations Alone Are Sufficient to Reduce Darunavir Susceptibility During Virological Failure to Boosted PI Therapy." J Antimicrob Chemother 2020.

Blanch-Lombarte, Oscar, et al. "HIV-1 Gag Mutations Alone Are Sufficient to Reduce Darunavir Susceptibility During Virological Failure to Boosted PI Therapy." J Antimicrob Chemother 2020.